2020
DOI: 10.4103/jomfp.jomfp_22_20
|View full text |Cite
|
Sign up to set email alerts
|

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
27
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(30 citation statements)
references
References 28 publications
1
27
1
1
Order By: Relevance
“…Cells expressing SOX2 could not be detected in normal parathyroid glands from normocalcemic subjects, but normal glands showed rare cells expressing OCT4 and NANOG. This observation resembles the few cells expressing core stem genes detected in normal oral epithelial cells or in cells of oral premalignant lesions [29]. Cells expressing the core stem genes were detected in a subset of parathyroid adenomas and in most parathyroid carcinomas.…”
Section: Discussionsupporting
confidence: 67%
“…Cells expressing SOX2 could not be detected in normal parathyroid glands from normocalcemic subjects, but normal glands showed rare cells expressing OCT4 and NANOG. This observation resembles the few cells expressing core stem genes detected in normal oral epithelial cells or in cells of oral premalignant lesions [29]. Cells expressing the core stem genes were detected in a subset of parathyroid adenomas and in most parathyroid carcinomas.…”
Section: Discussionsupporting
confidence: 67%
“…64 The attractive concept of CSCs, which holds that this population of cancer cells endowed with self-renewal and tumour-seeding potential could drive cancer initiation and progression, has been widely recognised. 62,65 Importantly, this concept provides an explanation for cancer heterogeneity that confers resistance to chemotherapeutic drugs, radiotherapy, targeted therapy and immunotherapy, accounting for the poor survival of LUAD patients. 66 Our previous studies have suggested that EHD1 plays roles in chemoresistance and EGFR-TKI resistance.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, the upregulated CD44 inhibits Hippo signalling activity, leading to nuclear entry of dephosphorylated YAP as well as a subsequent increase in the expression of downstream target genes (i.e. OCT4, SOX2, Nanog, CTGF and CYR61, which are related to stemness and/or EMT) 51,62 . Thus, EHD1 antagonises the Hippo pathway to enhance the CSCs‐like properties, EMT and metastasis of LUAD cells.…”
Section: Discussionmentioning
confidence: 99%
“…CSCs or tumor-initiating cells (TICs) represent a sub-population of cells that exhibit self-renewal ability and the capacity to differentiate. The undifferentiated state is maintained through the transcriptional regulation of four major transcription factors: SOX2, OCT4, and NANOG [ 74 , 75 , 76 , 77 ]. Moreover, compared with normal stem cells, CSCs are highly clonogenic.…”
Section: Cancer Stem Cells In Metastasismentioning
confidence: 99%